Cognition Therapeutics Announces Launch of its Initial Public Offering
PURCHASE, N.Y., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company engaged in the discovery and...
PURCHASE, N.Y., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company engaged in the discovery and...
DRAPER, Utah, Oct. 04, 2021 (GLOBE NEWSWIRE) -- HealthEquity (NASDAQ: HQY), the nation’s largest health savings account (HSA) non-bank custodian,...
Critical Next Step in Commercialization Plan CommencesFRAMINGHAM, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch”...
Preclinical neuroscience start-up honored for developing a platform of novel CNS compounds known as psychoplastogens to treat mental disorders at...
Appointment of New Director with Significant Experience in Drug Development, Licensing and CommercializationSAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) --...
TORONTO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"),...
New York, NY, and Tel Aviv, ISRAEL, Oct. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB:...
Large Population Screening Study Reached Key Milestone with Over 2,000 Confirmed CasesPHILADELPHIA, Oct. 04, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical...
OpGen’s Acuitas® AMR Gene Panel allows testing for a comprehensive panel of 28 genetic AMR markers in isolated bacterial colonies...
Oral presentation to discuss new data updates from the high- and low-dose cohorts from the ongoing Phase 1/2 trial of AXO-AAV-GM1...
Preliminary Total Revenue for Q3 2021 was approximately $1.2 millionCash as of September 30, 2021 was approximately $25.4 million, up...
EscharEx Treatment Demonstrated Superior Efficacy in Debridement of EscharYAVNE, Israel, Oct. 04, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD),...
- Natural History Study shows ectopic calcification and/or cardiovascular disease could serve as distinguishing characteristics of ENPP1 Deficiency in some...
Toronto, Ontario--(Newsfile Corp. - October 4, 2021) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("Leveljump" or the...
Plans to Develop and Launch A Global Registry For The Identification and Long Term Management of Current and Former Boxers...
Cincinnati, Ohio--(Newsfile Corp. - October 4, 2021) - NervGen Pharma Corp., through its subsidiary, NervGen US Inc., (TSXV: NGEN) (OTCQX:...
Toronto, Ontario--(Newsfile Corp. - October 4, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical...
Susan Kane Brings Over 30 Years of Industry Expertise and Leadership to the Nashville-based Healthcare Technology Company NASHVILLE, Tenn.--(BUSINESS WIRE)--HST...
LONDON--(BUSINESS WIRE)--#cardiovascular--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its third...
Impressive Customer Expansion in Key Verticals, New Partnerships and Creation of Strategic Advisory Board Underscores the Power of Democratizing IoT...